Pfizer 's Hospira plant in McPherson , Kansas has repeatedly breached the US Food and Drug Administration 's good practice standards since 2012 . The FDA ’s latest inspection of the company ’s human sterile drug manufacturing site between July and August 2018 recorded violations in 2017 , including an insufficient investigation into the discovered presence of cardboard in vials . USP, lot #80740LL” from 2017 until 5 February 2018. Violations dating from 2012 include failing to stop supposedly sterile drugs from being contaminated and laxity in reporting claims of not meeting established specifications with batches of a drug . Other violations include persistent manufacturing errors in certain areas and inadequate training of workers .
Pfizer 's Hospira plant in McPherson , Kansas has repeatedly breached the US Food and Drug Administration 's good practice standards since 2012 . The FDA ’s latest inspection of the company ’s human sterile drug manufacturing site between July and August 2018 recorded violations in 2017 , including an insufficient investigation into the discovered presence of cardboard in vials . Violations dating from 2012 include failing to stop supposedly sterile drugs from being contaminated and laxity in reporting claims of not meeting established specifications with batches of a drug . Other violations include persistent manufacturing errors in certain areas and inadequate training of workers .